Zolpidem impurities and related standards
Zolpidem is held here as a working collection of 77 reference materials across 32 CAS numbers. 36 of the entries are impurity-type materials of the parent, 1 are salt or counter-ion variants and 8 carry a deuterium label and 5 are nitrosamine analogues. 31 entries carry a verified structure drawing, a coverage of 40%; the rest are listed without a structure rather than with an unverified one. 30 of them sit in tier A or B, meaning the data behind the page is complete enough to be indexed and quoted directly, while 47 remain tier C and are kept for search coverage. Forced degradation on the parent tells you which of these materials a method will actually encounter: hydrolytic stress generates the amide and ester cleavage products, oxidative stress generates the N-oxides and hydroxylated analogues, and photolytic stress generates the ring rearrangements. A standard that is not on that list is usually a process impurity, and it is controlled by the route rather than by the formulation. For a laboratory setting specifications, the workable sequence is to fix the impurity list from the monograph and the degradation study first, and only then to source the standards, because the list determines which materials are worth holding.
Sources: DailyMed (US NLM) - ZOLPIDEM TARTRATE CAPSULE [TORRENT PHARMACEUTICALS LIMITED].
33 reference standards related to Zolpidem held in the RSSE catalogue — pharmacopoeial impurities, non-compendial impurities, metabolites and labelled analogues where available.
In this group: 11 impurity reference standards · 7 stable isotope labelled standards · 6 fine chemicals · 5 pharmaceutical intermediates. CAS numbers are listed for 33 of 33; 33 entries carry a structure drawing.
On this page
33 reference standards
All entries — structure, identifiers and pack sizes
-
Zolpidem
BACK ORDERRS-Z019018 -
Zolpidem CIV(Secondary Standards traceble to USP)
IN STOCKRS-Z019013 -
Zolpidem EP Impurity D
IN STOCKRS-Z019015 -
Zolpidem EP Impurity E
CUSTOM SYNTHESISRS-Z019014 -
(2E)-4-(4-Methylphenyl)-4-oxobut-2-enoic acid
IN STOCKRS-P012134 -
2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine
IN STOCKRS-P012049 -
2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine-3-acetic Acid
IN STOCKRS-P012036 -
Zolpidem USP Related Compound B
IN STOCKRS-Z019007 -
3-(Dimethylaminomethyl)-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine
IN STOCKRS-U068018 -
4-(3-methylphenyl)-4-oxobutanoic acid
BACK ORDERRS-U100798 -
Zolpidem EP Impurity C
IN STOCKRS-P011541 -
4-Methyl-N-(5-methyl-2-pyridinyl)benzamide
IN STOCKRS-U085146 -
5-Methyl Zolpidem
IN STOCKRS-I015159 -
6-Hydroxymethyl zolpidem
CUSTOM SYNTHESISRS-Z019017 -
6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-d6
IN STOCKRS-I094569 -
Ethyl 2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetate (PSY)
IN STOCKRS-D115055 -
Sulbenox
IN STOCKRS-Z401JIX -
Zolpidem Acid
CUSTOM SYNTHESISRS-U105018 -
Zolpidem Aldehyde
IN STOCKRS-Z019010 -
Zolpidem Carbaldehyde-d6
IN STOCKRS-Z019006 -
Zolpidem D6
IN STOCKRS-Z019016 -
Zolpidem IV
IN STOCKRS-Z019012 -
Zolpidem Phenyl-4-carboxylic Acid Ethyl Ester-d6
CUSTOM SYNTHESISRS-Z019005 -
Zolpidem-d6 6-Carboxylic Acid
IN STOCKRS-Z019003 -
Zolpidem-d6 6-Carboxylic Acid Methyl Ester
IN STOCKRS-Z019004 -
Zolpidem-d6 Phenyl-4-carboxylic Acid
CUSTOM SYNTHESISRS-Z019002 -
α-Hydroxyzolpidem
IN STOCKRS-Z019001 -
Zolpidem EP Impurity F
IN STOCKRS-Z019011 -
Zolpidem Impurity 5
IN STOCKRS-I516088 -
Zolpidem Impurity 6
IN STOCKRS-Z019009 -
Zolpidem Impurity 22
IN STOCKRS-Z019008 -
Zolpidem Impurity 23
IN STOCKRS-I001BDW
33 reference standards
Frequently asked
How many Zolpidem-related reference standards do you hold?
Can you supply a Zolpidem impurity that is not listed here?
What documentation is supplied with Zolpidem impurities?
Do you publish prices or a lead time for Zolpidem impurities?
Cannot find the impurity you need? Non-compendial impurities can be quoted from a structure — a CAS number is not required. Write to sales@rssechem.com.





![Chemical structure of 2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine](/structures/w4/JOQPDAAQTAOZFH-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine-3-acetic Acid](/structures/w4/NSLAIYSSTGSVPR-UHFFFAOYSA-N.webp?v=9)

![Chemical structure of 3-(Dimethylaminomethyl)-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine](/structures/w4/ZKSRNGXLVCJQCC-UHFFFAOYSA-N.webp?v=9)





![Chemical structure of 6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-d6](/structures/w4/AWEWSJJCANQFRB-ALEXJTRMSA-N.webp?v=9)
![Chemical structure of Ethyl 2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetate (PSY)](/structures/w4/RKFYYMREZGSLPU-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of N,N,N-Trimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methanaminium Iodide](/structures/w4/RZMYMHBVAQVDTA-UHFFFAOYSA-M.webp?v=9)















